Shanghai, China

Qianhui Huang

This inventor holds 1 USPTO granted patent. Top assignee: Mabwell (Shanghai) Bioscience Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qianhui Huang. Retrieved from https://idiyas.com/inventor/qianhui-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qianhui Huang: Innovator in Antibody Research

Introduction

Qianhui Huang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of bioscience, particularly in the development of antibodies. His work is essential for advancing medical research and therapeutic applications.

Latest Patents

Qianhui Huang holds a patent for an "ANTI-ST2 ANTIBODY, ENCODING NUCLEIC ACID MOLECULES THEREOF AND METHODS OF USE THEREOF." This patent represents a crucial advancement in the understanding and treatment of various diseases.

Career Highlights

He is currently employed at Mabwell (Shanghai) Bioscience Co., Ltd., where he continues to innovate and contribute to the field. His expertise in antibody research has positioned him as a valuable asset to his company and the scientific community.

Collaborations

Qianhui Huang collaborates with talented individuals such as Xinhui Xiong and Yang Zhang. Their combined efforts enhance the research capabilities at Mabwell and foster a collaborative environment for innovation.

Conclusion

Qianhui Huang's work in antibody research exemplifies the impact of innovation in the bioscience sector. His contributions are paving the way for future advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…